GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Total Current Liabilities

Origin Therapeutics Holdings (XCNQ:ORIG) Total Current Liabilities : C$0.11 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Origin Therapeutics Holdings's total current liabilities for the quarter that ended in Jun. 2023 was C$0.11


Origin Therapeutics Holdings Total Current Liabilities Historical Data

The historical data trend for Origin Therapeutics Holdings's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Total Current Liabilities Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Total Current Liabilities
0.18 0.16

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only 0.20 0.16 0.11 0.22 0.11

Origin Therapeutics Holdings Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Origin Therapeutics Holdings's Total Current Liabilities for the fiscal year that ended in Sep. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.159+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.16

Origin Therapeutics Holdings's Total Current Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.11+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Origin Therapeutics Holdings Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines

From GuruFocus

Ocean Rig: Growth And Dividends To Continue

By Faisal Humayun Faisal Humayun 05-11-2014

Third Avenue Value Fund 3rd Quarter Letter

By Holly LaFon Holly LaFon 11-01-2018

Transocean Ltd. Closes the Acquisition of Ocean Rig UDW Inc.

By Marketwired Marketwired 12-05-2018

5 Energy Stocks in Gurus' Portfolios

By Tiziano Frateschi Tiziano Frateschi 06-01-2018

Ocean Rig UDW Inc. Announces Updates to Rig Employment

By Marketwired Marketwired 07-23-2018